Skip to content

The effect of transforaminal chemical adhesiolysis in patients with epidural adhesion

The effect of transforaminal ventral epidural hypertonic adhesiolysis in patients with epidural adhesion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000500
Enrollment
68
Registered
2012-08-13
Start date
2010-12-30
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug, Procedure/Surgery : Patients will be randomly assigned into one of the two groups
hypertonic group and control group. The allocation of patients into either group is utilized by a computer-generated randomization program. The given randomization numbers are concealed throughout t

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Aged 20 years or older 2)Chronic lumbosacral radiculopathy secondary to spinal stenosis 3)Symptoms lasting for more than 12 weeks 4)Dominant leg pain with less severe back pain 5)Unilateral leg pain with the symptom restricted to one-level of dermatome 6)Failure of conservative management 7)Prior epidural injections not within 12 weeks before recruitment are permitted 8)Correlation between the clinically determined level of radiculopathy and the confirmed findings on the MRI

Exclusion criteria

Exclusion criteria: 1)NRS pain score >9 or <4 2)Signs of progressive motor weakness or neurologic deficits 3)Acute back or leg pain within 12 weeks 4)Allergic response to steroid or contrast dye 5)Bilateral radiculopathy, spondylolisthesis, multi-level spinal stenosis 6)History of prior spine surgery 7)Injection of steroids or hyaluronic acids within previous 12 weeks 8)Radiographic confirmation of severe central canal stenosis 9)Systemic infections, injection site infection 10)Unstable medical or psychiatric condition 11)Coagulopathy

Design outcomes

Primary

MeasureTime frame
11 point Numerical rating scale

Secondary

MeasureTime frame
Oswestry disability index;7 point Global percieved effect scale;type and number of adverse effects

Countries

Korea, Republic of

Contacts

Public ContactWonuk Koh

Asan Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026